Cathepsin G activity lowers plasma LDL and reduces atherosclerosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 11, 2014, Pages 2174-2183

  Wang, Jing ^a   Sjöberg, Sara ^a   Tang, Ting Ting ^b   Öörni, Katariina ^c   Wu, Wenxue ^a   Liu, Conglin ^a   Secco, Blandine ^a   Tia, Viviane ^a   Sukhova, Galina K ^a   Fernandes, Cleverson ^a   Lesner, Adam ^d   Kovanen, Petri T ^c   Libby, Peter ^a   Cheng, Xiang ^b   Shi, Guo Ping ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WIHURI RESEARCH INSTITUTE   (Finland)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

Angiotensin II; Atherosclerosis; Cathepsin G; Elastin; Low density lipoprotein

Indexed keywords

CATHEPSIN G; ELASTIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN DIET;

EID: 84908042364     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.07.026     Document Type: Article

References (59)

1. Helske S., Syvaranta S., Kupari M., Lappalainen J., Laine M., Lommi J., Turto H., Mayranpaa M., Werkkala K., Kovanen P.T., Lindstedt K.A. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur. Heart J. 2006, 27:1495-1504.
2. Owen C.A., Campbell E.J. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J. Immunol. 1998, 160:1436-1443.
3. Lindstedt K.A., Mayranpaa M.I., Kovanen P.T. Mast cells in vulnerable atherosclerotic plaques-a view to a kill. J. Cell. Mol. Med. 2007, 11:739-758.
4. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 2000, 105:1605-1612.
5. Schieffer B., Schieffer E., Hilfiker-Kleiner D., Hilfiker A., Kovanen P.T., Kaartinen M., Nussberger J., Harringer W., Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000, 101:1372-1378.
6. - mice. Hypertension 2004, 44:277-282.
7. Daien V., Duny Y., Ribstein J., du Cailar G., Mimran A., Villain M., Daures J.P., Fesler P. Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. Am. J. Hypertens. 2012, 25:126-132.
8. Kranzhofer R., Schmidt J., Pfeiffer C.A., Hagl S., Libby P., Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1623-1629.
9. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K., Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 1992, 267:21712-21719.
10. Shamamian P., Schwartz J.D., Pocock B.J., Monea S., Whiting D., Marcus S.G., Mignatti P. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J. Cell. Physiol. 2001, 189:197-206.
11. Saunders W.B., Bayless K.J., Davis G.E. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J. Cell Sci. 2005, 118:2325-2340.
12. Okada Y., Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett. 1989, 249:353-356.
13. Son E.D., Kim H., Choi H., Lee S.H., Lee J.Y., Kim S., Closs B., Lee S., Chung J.H., Hwang J.S. Cathepsin G increases MMP expression in normal human fibroblasts through fibronectin fragmentation, and induces the conversion of proMMP-1 to active MMP-1. J. Dermatol. Sci. 2009, 53:150-152.
14. Newby A.C. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2108-2114.
15. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 2013, 368:2004-2013.
16. Boudier C., Godeau G., Hornebeck W., Robert L., Bieth J.G. The elastolytic activity of cathepsin G: an ex vivo study with dermal elastin. Am. J. Respir. Cell Mol. Biol. 1991, 4:497-503.
17. Wang J., Sukhova G.K., Liu J., Ozaki K., Lesner A., Libby P., Kovanen P.T., Shi G.P. Cathepsin G deficiency reduces peri-aortic calcium chloride injury-induced abdominal aortic aneurysms in mice. J. Vasc. Surg. 2014, (in press).
18. Chatham W.W., Blackburn W.D., Heck L.W. Additive enhancement of neutrophil collagenase activity by HOCl and cathepsin G. Biochem. Biophys. Res. Commun. 1992, 184:560-567.
19. Kaschina E., Scholz H., Steckelings U.M., Sommerfeld M., Kemnitz U.R., Artuc M., Schmidt S., Unger T. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 2009, 205:396-403.
20. Mayranpaa M.I., Heikkila H.M., Lindstedt K.A., Walls A.F., Kovanen P.T. Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion. Coron. Artery Dis. 2006, 17:611-621.
21. Rafatian N., Karunakaran D., Rayner K.J., Leenen F.H., Milne R.W., Whitman S.C. Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H1141-H1148.
22. MacIvor D.M., Shapiro S.D., Pham C.T., Belaaouaj A., Abraham S.N., Ley T.J. Normal neutrophil function in cathepsin G-deficient mice. Blood 1999, 94:4282-4293.
23. Sukhova G.K., Zhang Y., Pan J.H., Wada Y., Yamamoto T., Naito M., Kodama T., Tsimikas S., Witztum J.L., Lu M.L., Sakara Y., Chin M.T., Libby P., Shi G.P. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 2003, 111:897-906.
24. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203.
25. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
26. Radding C.M., Steinberg D. Studies on the synthesis and secretion of serum lipoproteins by rat liver slices. J. Clin. Invest. 1960, 39:1560-1569.
27. Mayranpaa M.I., Trosien J.A., Fontaine V., Folkesson M., Kazi M., Eriksson P., Swedenborg J., Hedin U. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J. Vasc. Surg. 2009, 50:388-395. (discussion 395-386).
28. Lindmark A., Gullberg U., Olsson I. Processing and intracellular transport of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U-937-modulation by brefeldin A, ammonium chloride, and monensin. J. Leukoc. Biol. 1994, 55:50-57.
29. Owen C.A., Campbell M.A., Sannes P.L., Boukedes S.S., Campbell E.J. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 1995, 131:775-789.
30. Thomas M.P., Whangbo J., McCrossan G., Deutsch A.J., Martinod K., Walch M., Lieberman J. Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding proteins. J. Immunol. 2014, 192:5390-5397.
31. Ma Y., Wang W., Zhang J., Lu Y., Wu W., Yan H., Wang Y. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. PLoS One 2012, 7:e35835.
32. Choy K., Beck K., Png F.Y., Wu B.J., Leichtweis S.B., Thomas S.R., Hou J.Y., Croft K.D., Mori T.A., Stocker R. Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1684-1690.
33. Sukhova G.K., Wang B., Libby P., Pan J.H., Zhang Y., Grubb A., Fang K., Chapman H.A., Shi G.P. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ. Res. 2005, 96:368-375.
34. Biggs J.R., Yang J., Gullberg U., Muchardt C., Yaniv M., Kraft A.S. The human brm protein is cleaved during apoptosis: the role of cathepsin G. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3814-3819.
35. Sabri A., Alcott S.G., Elouardighi H., Pak E., Derian C., Andrade-Gordon P., Kinnally K., Steinberg S.F. Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J. Biol. Chem. 2003, 278:23944-23954.
36. Weir M.R., Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am. J. Hypertens. 1999, 12:205S-213S.
37. Oorni K., Pentikainen M.O., Ala-Korpela M., Kovanen P.T. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J. Lipid Res. 2000, 41:1703-1714.
38. Lee M., Metso J., Jauhiainen M., Kovanen P.T. Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells. J. Biol. Chem. 2003, 278:13539-13545.
39. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
40. van der Wal A.C., Becker A.E. Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovasc. Res. 1999, 41:334-344.
41. Farb A., Burke A.P., Tang A.L., Liang T.Y., Mannan P., Smialek J., Virmani R. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996, 93:1354-1363.
42. Cheng G.C., Loree H.M., Kamm R.D., Fishbein M.C., Lee R.T. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 1993, 87:1179-1187.
43. Van der Donckt C., Van Herck J.L., Schrijvers D.M., Vanhoutte G., Verhoye M., Blockx I., Van Der Linden A., Bauters D., Lijnen H.R., Sluimer J.C., Roth L., Van Hove C.E., Fransen P., Knaapen M.W., Hervent A.S., De Keulenaer G.W., Bult H., Martinet W., Herman A.G., De Meyer G.R. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur. Heart J. 2014, (in press).
44. Johnson J.L., Jackson C.L. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001, 154:399-406.
45. Liu J., Sukhova G.K., Sun J.S., Xu W.H., Libby P., Shi G.P. Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1359-1366.
46. Luttun A., Lutgens E., Manderveld A., Maris K., Collen D., Carmeliet P., Moons L. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 2004, 109:1408-1414.
47. Horvath A.J., Irving J.A., Rossjohn J., Law R.H., Bottomley S.P., Quinsey N.S., Pike R.N., Coughlin P.B., Whisstock J.C. The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J. Biol. Chem. 2005, 280:43168-43178.
48. Chandra T., Stackhouse R., Kidd V.J., Robson K.J., Woo S.L. Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III. Biochemistry 1983, 22:5055-5061.
49. Schechter N.M., Jordan L.M., James A.M., Cooperman B.S., Wang Z.M., Rubin H. Reaction of human chymase with reactive site variants of alpha 1-antichymotrypsin. Modulation of inhibitor versus substrate properties. J. Biol. Chem. 1993, 268:23626-23633.
50. Patston P.A. Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin. Inflammation 1995, 19:75-81.
51. Hollander C., Westin U., Wallmark A., Piitulainen E., Sveger T., Janciauskiene S.M. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency. BMC Pulm. Med. 2007, 7:1.
52. Owen C.A., Campbell M.A., Boukedes S.S., Campbell E.J. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J. Immunol. 1995, 155:5803-5810.
53. Skalen K., Gustafsson M., Rydberg E.K., Hulten L.M., Wiklund O., Innerarity T.L., Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002, 417:750-754.
54. Lindstedt L., Lee M., Castro G.R., Fruchart J.C., Kovanen P.T. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J. Clin. Invest. 1996, 97:2174-2182.
55. Paananen K., Kovanen P.T. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules. J. Biol. Chem. 1994, 269:2023-2031.
56. Lindstedt L., Lee M., Kovanen P.T. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid. Atherosclerosis 2001, 155:87-97.
57. Vijayagopal P., Srinivasan S.R., Radhakrishnamurthy B., Berenson G.S. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J. Biol. Chem. 1981, 256:8234-8241.
58. Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv. Lipid Res. 1982, 19:1-53.
59. Wagsater D., Johansson D., Fontaine V., Vorkapic E., Backlund A., Razuvaev A., Mayranpaa M.I., Hjerpe C., Caidahl K., Hamsten A., Franco-Cereceda A., Wilbertz J., Swedenborg J., Zhou X., Eriksson P. Serine protease inhibitor A3 in atherosclerosis and aneurysm disease. Int. J. Mol. Med. 2012, 30:288-294.